Wyeth ( WYE) reported that its first-quarter earnings were flat compared with a year ago, and said revenue declined 6% as a stronger dollar overseas cut into returns.

The Madison, N.J., drugmaker had net income of $1.2 billion, or 89 cents a diluted share, on revenue of $5.4 billion.

Excluding charges of $71.8 million for cost-cutting measures, the company earned 93 cents a share. Analysts on average were expecting EPS of 88 cents a share and revenue of $5.52 billion.

In the first quarter last year, Wyeth had revenue of $5.7 billion. The company attributed its wider profit margins in 2009 to cost cutting measures and a lower tax rate.

The company also said that, taking into account currency fluctuations, its revenue for the quarter increased 2% from a year ago, though several important product lines experienced weakness in the period. Sales of the popular antidepressant Effexor, for example, tumbled 20% from a year ago to $819 million, hurt by stronger competition from generics.

Wyeth shares were trading down slightly Wednesday morning at 42.11, off less than 1%.
Copyright 2009 TheStreet.com Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. AP contributed to this report.

If you liked this article you might like

The Most Beloved Brands in America

CEOs Focus on Growth in 2010

CEOs Focus on Growth in 2010

A Peek at Jim Cramer's Portfolio

Glaxo, Wyeth Cut Costs With Trial Software

Glaxo, Wyeth Cut Costs With Trial Software

Biotech Stock Mailbag: Oncothyreon

Biotech Stock Mailbag: Oncothyreon